339 related articles for article (PubMed ID: 25815848)
1. Metabolism and its sequelae in cancer evolution and therapy.
Gillies RJ; Gatenby RA
Cancer J; 2015; 21(2):88-96. PubMed ID: 25815848
[TBL] [Abstract][Full Text] [Related]
2. Why do cancers have high aerobic glycolysis?
Gatenby RA; Gillies RJ
Nat Rev Cancer; 2004 Nov; 4(11):891-9. PubMed ID: 15516961
[TBL] [Abstract][Full Text] [Related]
3. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA; Gawlinski ET
Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971
[TBL] [Abstract][Full Text] [Related]
4. Causes and consequences of increased glucose metabolism of cancers.
Gillies RJ; Robey I; Gatenby RA
J Nucl Med; 2008 Jun; 49 Suppl 2():24S-42S. PubMed ID: 18523064
[TBL] [Abstract][Full Text] [Related]
5. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
Gillies RJ; Gatenby RA
J Bioenerg Biomembr; 2007 Jun; 39(3):251-7. PubMed ID: 17624581
[TBL] [Abstract][Full Text] [Related]
6. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes during carcinogenesis: potential impact on invasiveness.
Smallbone K; Gatenby RA; Gillies RJ; Maini PK; Gavaghan DJ
J Theor Biol; 2007 Feb; 244(4):703-13. PubMed ID: 17055536
[TBL] [Abstract][Full Text] [Related]
8. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
9. Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy.
Gravenmier CA; Siddique M; Gatenby RA
Bull Math Biol; 2018 May; 80(5):954-970. PubMed ID: 28508297
[TBL] [Abstract][Full Text] [Related]
10. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
11. Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.
Justus CR; Sanderlin EJ; Yang LV
Int J Mol Sci; 2015 May; 16(5):11055-86. PubMed ID: 25988385
[TBL] [Abstract][Full Text] [Related]
12. Cancer proliferation and therapy: the Warburg effect and quantum metabolism.
Demetrius LA; Coy JF; Tuszynski JA
Theor Biol Med Model; 2010 Jan; 7():2. PubMed ID: 20085650
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
14. Causes, consequences, and therapy of tumors acidosis.
Pillai SR; Damaghi M; Marunaka Y; Spugnini EP; Fais S; Gillies RJ
Cancer Metastasis Rev; 2019 Jun; 38(1-2):205-222. PubMed ID: 30911978
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic changes of acid-adapted cancer cells push them toward aggressiveness in their evolution in the tumor microenvironment.
Damaghi M; Gillies R
Cell Cycle; 2017 Oct; 16(19):1739-1743. PubMed ID: 27635863
[TBL] [Abstract][Full Text] [Related]
16. The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela.
Cardone RA; Alfarouk KO; Elliott RL; Alqahtani SS; Ahmed SBM; Aljarbou AN; Greco MR; Cannone S; Reshkin SJ
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357694
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
18. The influence of pH and hypoxia on tumor metastasis.
Abaza M; Luqmani YA
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1229-42. PubMed ID: 24099530
[TBL] [Abstract][Full Text] [Related]
19. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
20. Computational modeling to determine key regulators of hypoxia effects on the lactate production in the glycolysis pathway.
Hashemzadeh S; Shahmorad S; Rafii-Tabar H; Omidi Y
Sci Rep; 2020 Jun; 10(1):9163. PubMed ID: 32514127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
